368 related articles for article (PubMed ID: 24408118)
21. Viral load and duration of BK polyomavirus viraemia determine renal graft fibrosis progression: histologic evaluation of late protocol biopsies.
Reischig T; Kacer M; Hes O; Machova J; Nemcova J; Kormunda S; Pivovarcikova K; Bouda M
Nephrol Dial Transplant; 2019 Nov; 34(11):1970-1978. PubMed ID: 31071208
[TBL] [Abstract][Full Text] [Related]
22. Clinical Characteristic and Outcomes of BK Virus Infection in Kidney Transplant Recipients Managed Using a Systematic Surveillance and Treatment Strategy.
Lee S; Lee KW; Kim SJ; Park JB
Transplant Proc; 2020; 52(6):1749-1756. PubMed ID: 32402452
[TBL] [Abstract][Full Text] [Related]
23. Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy.
Kaul A; Kumar S; Bhaduaria D; Agrawal V; Sharma RK; Prasad N; Gupta A; Kumar R
Saudi J Kidney Dis Transpl; 2018; 29(1):101-106. PubMed ID: 29456214
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and risk factors of polyomavirus BK replication in simultaneous pancreas/kidney transplant recipients from a single transplant center.
Mindlova M; Boucek P; Saudek F; Skibova J; Jedinakova T; Lipar K; Adamec M; Hirsch HH
Clin Transplant; 2012; 26(2):267-74. PubMed ID: 21854452
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous pancreas/kidney transplant recipients present with late-onset BK polyomavirus-associated nephropathy.
Schachtner T; Zaks M; Kahl A; Reinke P
Nephrol Dial Transplant; 2016 Jul; 31(7):1174-82. PubMed ID: 26758790
[TBL] [Abstract][Full Text] [Related]
26. Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients.
Sharif A; Alachkar N; Bagnasco S; Geetha D; Gupta G; Womer K; Arend L; Racusen L; Montgomery R; Kraus E
Clin J Am Soc Nephrol; 2012 Aug; 7(8):1320-7. PubMed ID: 22626962
[TBL] [Abstract][Full Text] [Related]
27. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
[TBL] [Abstract][Full Text] [Related]
28. Prospective study of BK virus infection and nephropathy during the first year after kidney transplantation.
Soleymanian T; Keyvani H; Jazayeri SM; Fazeli Z; Ghamari S; Mahabadi M; Chegeni V; Najafi I; Ganji MR
Iran J Kidney Dis; 2014 Mar; 8(2):145-51. PubMed ID: 24685738
[TBL] [Abstract][Full Text] [Related]
29. Predictive Factors of BK Virus Development in Kidney Transplant Recipients and the Effect of Low-Dose Tacrolimus Plus Everolimus on Clinical Outcomes.
Yilmaz VT; Kisaoglu A; Avanaz A; Dandin O; Ozel D; Mutlu D; Akkaya B; Aydinli B; Kocak H
Exp Clin Transplant; 2023 Sep; 21(9):727-734. PubMed ID: 37885288
[TBL] [Abstract][Full Text] [Related]
30. BK viremia is not associated with adverse outcomes in the absence of BK nephropathy.
Hertz-Tang AL; Astor BC; Mandelbrot DA; Mohamed MA; Djamali A; Parajuli S
Clin Transplant; 2018 Jul; 32(7):e13283. PubMed ID: 29774593
[TBL] [Abstract][Full Text] [Related]
31. Clinical characteristics and outcomes of late-onset BK virus nephropathy in kidney and kidney-pancreas transplant recipients.
Imlay H; Whitaker K; Fisher CE; Limaye AP
Transpl Infect Dis; 2018 Aug; 20(4):e12928. PubMed ID: 29809315
[TBL] [Abstract][Full Text] [Related]
32. Combination of Leflunomide and Everolimus for treatment of BK virus nephropathy.
Jaw J; Hill P; Goodman D
Nephrology (Carlton); 2017 Apr; 22(4):326-329. PubMed ID: 28247521
[TBL] [Abstract][Full Text] [Related]
33. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
[TBL] [Abstract][Full Text] [Related]
34. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
[TBL] [Abstract][Full Text] [Related]
35. Low prevalence of BK virus nephropathy on nonprotocol renal biopsies in Iranian kidney transplant recipients: one center's experience and review of the literature.
Soleymanian T; Rasulzadegan MH; Sotoodeh M; Ganji MR; Naderi G; Amin M; Saddadi F; Hakemi M; Najafi I
Exp Clin Transplant; 2010 Dec; 8(4):297-302. PubMed ID: 21143095
[TBL] [Abstract][Full Text] [Related]
36. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year.
Wojciechowski D; Chanda R; Chandran S; Lee B; Webber A; Macaraig M; Tomlanovich S; Vincenti F
Transplantation; 2012 Dec; 94(11):1117-23. PubMed ID: 23060281
[TBL] [Abstract][Full Text] [Related]
37. The status of BK polyomavirus replication in adult renal transplant recipients in northeastern Poland.
Naumnik B; Kowalewska J; Zalewski G; Charkiewicz R; Myśliwiec M
Transplant Proc; 2011 Oct; 43(8):2976-84. PubMed ID: 21996205
[TBL] [Abstract][Full Text] [Related]
38. Variability in assessing for BK viremia: whole blood is not reliable and plasma is not above reproach - a retrospective analysis.
Agrawal N; Echenique IA; Meehan SM; Limaye AP; Cook L; Chang A; Harland RC; Javaid B; Kadambi PV; Matushek S; Williams J; Josephson MA
Transpl Int; 2017 Jul; 30(7):670-678. PubMed ID: 28295760
[TBL] [Abstract][Full Text] [Related]
39. Monitoring the BK virus in liver transplant recipients: a prospective observational study.
Demir-Onder K; Avkan-Oguz V; Unek T; Sarioglu S; Sagol O; Astarcioglu I
Exp Clin Transplant; 2014 Oct; 12(5):429-36. PubMed ID: 24679112
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients.
Vu D; Shah T; Ansari J; Naraghi R; Min D
Transplant Proc; 2015 Mar; 47(2):394-8. PubMed ID: 25769580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
